Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+402K
-
Total reported value, excl. options
-
$451M
-
Value change
-
+$562K
-
Put/Call ratio
-
1.06
-
Number of buys
-
64
-
Number of sells
-
-77
-
Price
-
$16.97
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q4 2024
190 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q4 2024.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 27.1M outstanding shares and own 98.06% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.69M shares), BlackRock, Inc. (2.99M shares), Sumitomo Mitsui Trust Group, Inc. (2.07M shares), Nikko Asset Management Americas, Inc. (2.07M shares), ARK Investment Management LLC (1.93M shares), VANGUARD GROUP INC (1.68M shares), STATE STREET CORP (1.33M shares), Schonfeld Strategic Advisors LLC (849K shares), Woodline Partners LP (807K shares), and DIMENSIONAL FUND ADVISORS LP (707K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.